Updated investor presentation

(Thomson Reuters ONE) - Oslo, 21 January 2010 - Attached is an updated investor presentation of PCIBiotech.  The presentation will be used in meetings with potential investors inLondon today, 21(st) January 2010.Contact information:PCI Biotech Holding ASA, Strandveien 55, N-1366 LysakerPer Walday, CEO, pw(at)pcibiotech.no, Mobile: +47 917 93 429Bernt-Olav R?ngsnes, CFO, bor(at)pcibiotech.no, Mobile: +47 913 47 021This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act)[HUG#1375439] PCI Biotech Investor Presentation: http://hugin.info/139147/R/1375439/337451.pdf

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 21.01.2010 - 10:02 Uhr
Sprache: Deutsch
News-ID 11258
Anzahl Zeichen: 0

contact information:
Town:

Oslo

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 180 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Updated investor presentation"
steht unter der journalistisch-redaktionellen Verantwortung von

PCI Biotech Holding (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Initiated pre-clinical trials for the use of PCI in the treatment of Bladder Can ...

PCI Biotech has initiated pre-clinical trials for the use of Photochemical Internalisation (PCI) in the treatment of Bladder cancer. The pre-clinical trials will be concluded during the first half of 2010, and a phase I/II study (first in man) is exp ...

PCI Biotech - Financial calendar for 2010: ...

19 February 2010 - Presentation of the fourth quarter 2009 report 27 April 2010 - Presentation of the first quarter 2010 report 27 April 2010 - Annual General Meeting 24 August 2010 - Presentation of the second quarter 2010 report 26 October 2010 - P ...

3rd Quarter 2009 Report ...

Oslo, Norway, 27 October 2009. Please find attached the third quarter report 2009 for PCI Biotech Holding ASA. Kind regards, Per Walday CEO Email: pw@pcibiotech.no Mobil: +47 917 93 429 http://hugin.info/139147/R/1350200/325656.pdf This annou ...

Alle Meldungen von PCI Biotech Holding